These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22384088)

  • 1. Evaluation of functional erythropoietin receptor status in skeletal muscle in vivo: acute and prolonged studies in healthy human subjects.
    Christensen B; Lundby C; Jessen N; Nielsen TS; Vestergaard PF; Møller N; Pilegaard H; Pedersen SB; Kopchick JJ; Jørgensen JO
    PLoS One; 2012; 7(2):e31857. PubMed ID: 22384088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin receptor in human skeletal muscle and the effects of acute and long-term injections with recombinant human erythropoietin on the skeletal muscle.
    Lundby C; Hellsten Y; Jensen MB; Munch AS; Pilegaard H
    J Appl Physiol (1985); 2008 Apr; 104(4):1154-60. PubMed ID: 18218911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin does not activate erythropoietin receptor signaling or lipolytic pathways in human subcutaneous white adipose tissue in vivo.
    Christensen B; Nellemann B; Jørgensen JO; Pedersen SB; Jessen N
    Lipids Health Dis; 2016 Sep; 15(1):160. PubMed ID: 27640183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged erythropoietin treatment does not impact gene expression in human skeletal muscle.
    Christensen B; Nellemann B; Thorsen K; Nielsen MM; Pedersen SB; Ornstrup MJ; JØrgensen JO; Jessen N
    Muscle Nerve; 2015 Apr; 51(4):554-61. PubMed ID: 25088500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the erythropoietin receptor in human skeletal muscle.
    Rundqvist H; Rullman E; Sundberg CJ; Fischer H; Eisleitner K; Ståhlberg M; Sundblad P; Jansson E; Gustafsson T
    Eur J Endocrinol; 2009 Sep; 161(3):427-34. PubMed ID: 19515792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin Reduces Insulin Resistance via Regulation of Its Receptor-Mediated Signaling Pathways in
    Pan Y; Yang XH; Guo LL; Gu YH; Qiao QY; Jin HM
    Int J Biol Sci; 2017; 13(10):1329-1340. PubMed ID: 29104499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT5 as a Key Protein of Erythropoietin Signalization.
    Tóthová Z; Tomc J; Debeljak N; Solár P
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
    Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
    Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
    World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
    De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
    Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus.
    Jørgensen JO; Jessen N; Pedersen SB; Vestergaard E; Gormsen L; Lund SA; Billestrup N
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E899-905. PubMed ID: 16757551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
    Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X
    Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle alterations and exercise performance decrease in erythropoietin-deficient mice: a comparative study.
    Mille-Hamard L; Billat VL; Henry E; Bonnamy B; Joly F; Benech P; Barrey E
    BMC Med Genomics; 2012 Jun; 5():29. PubMed ID: 22748015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.
    Mohyeldin A; Lu H; Dalgard C; Lai SY; Cohen N; Acs G; Verma A
    Neoplasia; 2005 May; 7(5):537-43. PubMed ID: 15967106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute erythropoietin injection increases muscle mitochondrial respiratory capacity in young men: a double-blinded randomized crossover trial.
    Larsen S; Dam Søndergård S; Eg Sahl R; Frandsen J; Morville T; Dela F; Helge JW
    J Appl Physiol (1985); 2021 Oct; 131(4):1340-1347. PubMed ID: 34498946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
    Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of receptor-mediated elimination of erythropoietin by analysis of erythropoietin receptor mRNA expression in bone marrow and erythropoietin clearance during anemia.
    Nalbant D; Saleh M; Goldman FD; Widness JA; Veng-Pedersen P
    J Pharmacol Exp Ther; 2010 May; 333(2):528-32. PubMed ID: 20103588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
    Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
    Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.